Mental Health
From the Journals
Increased awareness needed of bipolar disorder in primary care
Depending on the study, the prevalence of unrecognized bipolar disorder in depressed primary care patients ranged from 5%-28%.
Latest News
Mindfulness-based stress reduction reduces migraine frequency
SAN ANTONIO – The intervention also led to reductions in anxiety, depression, and stress symptoms and an increase in gray matter volume.
Conference Coverage
Consider iatrogenesis in patients with new psychiatric symptoms
CRYSTAL CITY, VA. – “Iatrogenic psychopathology can occur with a wide array of medications,” said Dr. Henry A. Nasrallah.
Conference Coverage
Patients with mood disorders may have altered microbiome
CRYSTAL CITY, VA. – “It’s becoming clear that [the microbiome is] integral for the modulation of the central nervous system,” said Dr. Emily G....
From the Journals
Suicide rates rise in U.S. adolescents and young adults
Males aged 15-19 years had the greatest increase in suicides, with a 14% annual percentage change increase from 2015 to 2017.
Conference Coverage
Ask patients about worst example of suicidal ideation
ARLINGTON, Va. – “Most people with a major depressive episode never attempt suicide,” Dr. J. John Mann said.
From the Journals
LTC-associated suicide among older adults more common than previously thought
Deaths while living in LTC were more likely among women, which the investigators noted is to be expected because LTC residents are...
From the Journals
More evidence supports psychotherapy as first-line therapy for PTSD
“We found limited evidence to recommend pharmacological treatments as monotherapies,” the investigators noted.
Latest News
Deaths from drugs, alcohol, and suicide increase among millennials
‘Deaths of despair’ in the United States increased to an all-time high in 2017, and the increase was especially pronounced among young adults,...
Feature
FDA overlooked red flags in esketamine testing
Though esketamine was greeted with public applause, some deep misgivings were expressed during its advisory committee meeting and in the FDA...
From the Journals
Intranasal esketamine plus antidepressant deflects relapse
Esketamine nasal spray in addition to oral antidepressant treatment was superior to antidepressant plus placebo for preventing depression relapse...